Catalog Home Page

Publications: Centre for Molecular Medicine and Innovative Therapeutics (CMMIT)

Export as [feed] RSS
Group by: Item Type | Year
Number of items at this level: 28.

Journal Article

Aung-Htut, M.T., Ham, K.A., Tchan, M.C., Fletcher, S. and Wilton, S.D. (2020) Novel mutations found in individuals with adult-onset Pompe disease. Genes, 11 (2). Article 135.

Aung-Htut, M.T., McIntosh, C.S., Ham, K.A., Pitout, I.L., Flynn, L.L., Greer, K., Fletcher, S. and Wilton, S.D. (2019) Systematic approach to developing splice modulating antisense oligonucleotides. International Journal of Molecular Sciences, 20 (20). Article 5030.

Aung-Htut, M.T., McIntosh, C.S., West, K.A., Fletcher, S. and Wilton, S.D. (2019) In Vitro Validation of Phosphorodiamidate Morpholino Oligomers. Molecules, 24 (16). p. 2922.

Brini, S., Sohrabi, H.R., Hebert, J.J., Forrest, M.R.L., Laine, M., Hämäläinen, H., Karrasch, M., Peiffer, J.J.ORCID: 0000-0002-3331-1177, Martins, R.N. and Fairchild, T.J.ORCID: 0000-0002-3975-2213 (2020) Bilingualism is associated with a delayed onset of dementia but not with a lower risk of developing it: a Systematic review with Meta-Analyses. Neuropsychology Review, 30 . pp. 1-24.

Chakravarthy, M. and Veedu, R.N. (2019) BACE1 inhibition using 2’-OMePS steric blocking antisense oligonucleotides. Genes, 10 (9).

Chen, S., Le, B.T., Chakravarthy, M., Kosbar, T.R. and Veedu, R.N. (2019) Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro. Scientific Reports, 9 (1). Article number 6078.

Eltermaa, M., Jakobson, M., Utt, M., Kõks, S., Mägi, R. and Starkopf, J. (2019) Genetic variants in humanin nuclear isoform gene regions show no association with coronary artery disease. BMC Research Notes, 12 (1).

Gorecki, A.M., Preskey, L., Bakeberg, M.C., Kenna, J.E., Gildenhuys, C., MacDougall, G., Dunlop, S.A., Mastaglia, F.L., Akkari, P.A., Koengten, F. and Anderton, R.S. (2019) Altered gut microbiome in Parkinson’s disease and the influence of lipopolysaccharide in a human α-Synuclein over-expressing mouse model. Frontiers in Neuroscience, 13 . Article number 839.

Keegan, N.P. (2020) Pseudoexons of the DMD Gene. Journal of Neuromuscular Diseases, 7 (2). pp. 77-95.

Keegan, N.P., Wilton, S.D. and Fletcher, S. (2019) Breakpoint junction features of seven DMD deletion mutations. Human Genome Variation, 6 (1).

Kõks, S., Ho, X.D., Maasalu, K., Wood, D. and Martson, A. (2019) Analysis of alternative spicing in the transcriptome of osteosarcoma. Asia-Pacific Journal of Clinical Oncology, 15 (S9). pp. 56-102.

Kõks, S., Wood, D.J., Reimann, E., Awiszus, F., Lohmann, C.H., Bertrand, J., Prans, E., Maasalu, K. and Märtson, A. (2019) The genetic variations associated with time to aseptic loosening after total joint arthroplasty. The Journal of Arthroplasty . In Press.

Larcher, L.M., Wang, T. and Veedu, R.N. (2019) Development of novel antimiRzymes for targeted inhibition of miR-21 expression in solid cancer cells. Molecules, 24 (13). p. 2489.

Martinovich, K.M., Kicic, A., Fletcher, S., Wilton, S.D. and Stick, S.M. (2019) Antisense oligonucleotides to improve CFTR function for people with the INTRON 9 5T polymorphism. Pediatric Pulmonology, 54 (S2). S217-S218.

McIntosh, C.S., Aung-Htut, M.T., Fletcher, S. and Wilton, S.D. (2019) Removal of the polyglutamine repeat of ataxin-3 by redirecting pre-mRNA processing. International Journal of Molecular Sciences, 20 (21). Article 5434.

Mejzini, R., Flynn, L.L., Pitout, I.L., Fletcher, S., Wilton, S.D. and Akkari, P.A. (2019) ALS genetics, mechanisms, and therapeutics: Where are we now? Frontiers in Neuroscience, 13 .

Pitout, I., Flynn, L.L., Wilton, S.D. and Fletcher, S. (2019) Antisense-mediated splice intervention to treat human disease: the odyssey continues. F1000Research, 8 .

Pytte, J., Anderton, R.S., Flynn, L.L., Theunissen, F., Jiang, L., Pitout, I., James, I., Mastaglia, F.L., Saunders, A.M., Bedlack, R., Siddique, T., Siddique, N. and Akkari, P.A. (2020) Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis. Neurology Genetics, 6 (2). Art. e406.

Theunissen, F., Flynn, L.L., Anderton, R.S., Mastaglia, F., Pytte, J., Jiang, L., Hodgetts, S., Burns, D.K., Saunders, A., Fletcher, S., Wilton, S.D. and Akkari, P.A. (2020) Structural variants may be a source of missing heritability in sALS. Frontiers in Neuroscience, 14 .

Thomas, P.B., Jeffery, P.L., Manuel, G.D., Whiteside, E.J., Maugham, M., Walpole, C., Gunter, J.H., Williams, E.D., Nelson, C.C., Herington, A.C., Luque, R.M., Veedu, R.N., Chopin, L.K. and Seim, I. (2018) Abstract 2452: Dysregulated expression of the human long noncoding RNAGHSROSmay influence prostate cancer progression and resistance to docetaxe. Cancer Research, 78 (13 Supp.). p. 2452.

Vetkas, A., Prans, E., Kõks, S., Rätsep, T. and Asser, T. (2020) Aneurysmal subarachnoid haemorrhage: Effect of CRHR1 genotype on mental health-related quality of life. Scientific Reports, 10 (1).

Vollstedt, E‐J, Kasten, M., Klein, C., Aasly, J., Adler, C., Ahmad‐Annuar, A., Albanese, A., Alcalay, R., Al‐Mubarak, B., Alvarez, V., Andree‐Muñoz, B., Annesi, G., Appel‐Cresswell, S., Arkadir, D., Armasu, S., Barber, T.R., Bardien, S., Barkhuizen, M., Barrett, M.J., BaŞak, A.N., Beach, T., Benitez, B.A., Berg, D., Bhatia, K., Binkofski, F., Blauwendraat, C., Bonifati, V., Borges, V., Bozi, M., Brice, A., Brighina, L., Brockmann, K., Brüggemann, N., Camacho, M., Cardoso, F., Belin, A.C., Carr, J., Chan, P., Chang‐Castello, J., Chase, B., Chen‐Plotkin, A., Chung, S.J., Cilia, R., Clarimon, J., Clark, L., Cornejo‐Olivas, M., Corvol, J‐C, Cosentino, C., Cras, P., Crosiers, D., Damásio, J., Das, P., Carvalho Aguiar, P., De Michele, G., De Rosa, A., Dieguez, E., Dorszewska, J., Erer, S., Ertan, S., Farrer, M., Fedotova, E., Ferese, R., Ferrarese, C., Ferraz, H., Fiala, O., Foroud, T., Friedman, A., Frigerio, R., Funayama, M., Gambardella, S., Garraux, G., Gatto, E.M., Genç, G., Goldwurm, S., Gomez‐Esteban, J.C., Gómez‐Garre, P., Gorostidi, A., Grosset, D., Hanagasi, H., Hardy, J., Hassan, A., Hattori, N., Hauser, R.A., Hedera, P., Hentati, F., Hertz, J.M., Holton, J.L., Houlden, H., Hutz, M.H., Ikeuchi, T., Illarioshkin, S., Inca‐Martinez, M., Infante, J., Jankovic, J., Jeon, B.S., Jesús, S., Jimenez‐Del‐Rio, M., Kasten, M., Kataoka, H., Kawakami, H., Kim, Y.J., Klein, C., Klivényi, P., Kõks, S., König, I.R., KostiĆ, V., Koziorowski, D., Krüger, R., Krygowska‐Wajs, A., Kulisevsky, J., Lang, A., LeDoux, M., Lesage, S., Lim, S‐Y, Lin, C‐H, Lohmann, K., Lopera, F., Lopez, G., Lu, C‐S, Lynch, T., Machaczka, M., Madoev, H., Magalhães, M., Majamaa, K., Maraganore, D., Marder, K., Markopoulou, K., Martikainen, M.H., Mata, I., Mazzetti, P., Mellick, G., Menéndez‐González, M., Micheli, F., Mirelman, A., Mir, P., Morino, H., Morris, H., Munhoz, R.P., Naito, A., Olszewska, D.A., Ozelius, L.J., Padmanabhan, S., Paisán‐Ruiz, C., Payami, H., Peluso, S., Petkovic, S., Petrucci, S., Pezzoli, G., Pimentel, M., Pirker, W., Pramstaller, P.P., Pulkes, T., Puschmann, A., Quattrone, A., Raggio, V., Ransmayr, G., Rieder, C., Riess, O., Rodriguez‐Porcel, F., Rogaeva, E., Ross, O.A., Ruiz‐Martinez, J., Sammler, E., Luciano, M.S., Satake, W., Saunders‐Pullman, R., Sazci, A., Scherzer, C., Schrag, A., Schumacher‐Schuh, A., Sharma, M., Sidransky, E., Singleton, A.B., Petersen, M.S., Smolders, S., Spitz, M., Stefanis, L., Struhal, W., Sue, C., Swan, M., Swanberg, M., Taba, P., Taipa, R., Tan, M., Tan, A.H., Tan, E‐K, Tang, B., Tayebi, N., Thaler, A., Thomas, A., Toda, T., Toft, M., Torres, L., Tumas, V., Valente, E.M., Van Broeckhoven, C., Vecsei, L., Velez‐Pardo, C., Vidailhet, M., Vollstedt, E‐J, Warner, T.T., Williams‐Gray, C.H., Winkelmann, J., Woitalla, D., Wood, N.W., Wszolek, Z.K., Wu, R‐M, Wu, Y‐R, Xie, T., Yoshino, H., Zhang, B. and Zimprich, A. (2019) Using global team science to identify genetic Parkinson's disease worldwide. Annals of Neurology, 86 (2). pp. 153-157.

Wang, T., Philippovich, S., Mao, J. and Veedu, R.N. (2019) Efficient epidermal growth factor receptor targeting oligonucleotide as a potential molecule for targeted cancer therapy. International Journal of Molecular Sciences, 20 (19).

Wang, T., Rahimizadeh, K. and Veedu, R.N. (2019) Development of a novel DNA oligonucleotide targeting low-density lipoprotein receptor. Molecular Therapy - Nucleic Acids, 19 . pp. 190-198.

Yang, D., Zhang, W., Zhang, H., Zhang, F., Chen, L., Ma, L., Larcher, L.M., Chen, S., Liu, N., Zhao, Q., Tran, P.H.L., Chen, C., Veedu, R.N. and Wang, T. (2020) Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics, 10 (8). pp. 3684-3707.

Zamani Esteki, M., Viltrop, T., Tšuiko, O., Tiirats, A., Koel, M., Nõukas, M., Žilina, O., Teearu, K., Marjonen, H., Kahila, H., Meekels, J., Söderström-Anttila, V., Suikkari, A-M, Tiitinen, A., Mägi, R., Kõks, S., Kaminen-Ahola, N., Kurg, A., Voet, T., Vermeesch, J.R. and Salumets, A. (2019) In vitro fertilization does not increase the incidence of de novo copy number alterations in fetal and placental lineages. Nature Medicine, 25 (11). pp. 1699-1705.

Zaw, K., Greer, K., Aung-Htut, M.T., Mitrpant, C., Veedu, R.N., Fletcher, S. and Wilton, S.D. (2019) Consequences of making the inactive active through changes in antisense oligonucleotide chemistries. Frontiers in Genetics, 10 .

Book Chapter

González-Navarro, H., Dogan, S., Tuna, B.G., Potter, P.K., Kõks, G. and Kõks, S. (2019) Aging in rodents. In: Rattan, S.I.S., (ed.) Reference Module in Biomedical Sciences. Academic Press, pp. 73-87.

This list was generated on Wed Apr 8 09:45:08 2020 UTC.